Zobrazeno 1 - 10 of 30 pro vyhledávání: '"Harumi Kuno-Sakai"'
1
Removal of gelatin from live vaccines and DTaP—an ultimate solution for vaccine-related gelatin allergy
Autor: Harumi Kuno-Sakai, Mikio Kimura
Publikováno v: Biologicals. 31:245-249
From the early 1990s infants started to receive acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP) before live vaccines such as measles, rubella, and mumps vaccines, which contained gelatin as a stabilizer. Then, an incre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9c8b2273bd2bfa06291602b36c1e4a3
https://doi.org/10.1016/s1045-1056(03)00063-0
Zobrazit plný text záznamu
2
A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids
Autor: Harumi Kuno-Sakai, Chikara Aizawa, Tetsuo Nakayama
Publikováno v: Journal of Allergy and Clinical Immunology. 103:321-325
Background: The number of patients with allergic reactions after administration of gelatin-containing live vaccines is increasingly reported in Japan. These allergic reactions appear to be caused by gelatin allergy. It is still unknown how the patien
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ba710e916d974e53f3d3244fca3a13d6
https://doi.org/10.1016/s0091-6749(99)70508-7
Zobrazit plný text záznamu
3
Developments in mucosal influenza virus vaccines
Autor: Harumi Kuno-Sakai, Yasumasa Oh, Kazuyo Ohta, Mikio Kimura, Rumi Shimojima, Hideo Fukumi
Publikováno v: Vaccine. 12:1303-1310
Immunogenicity and efficacy of aerosol inactivated split influenza virus vaccines, which are threefold the strength of the vaccines for parenteral use, and cold-adapted reassortant live influenza virus vaccines were evaluated. Mucosal immune response
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f644122ca3d81450e52167ec087fb09
https://doi.org/10.1016/s0264-410x(94)80056-6
Zobrazit plný text záznamu
4
Local and systemic influenza haemagglutinin-specific antibody responses following aerosol and subcutaneous administration of inactivated split influenza vaccine
Autor: Kazuyo Ohta, Harumi Kuno-Sakai, Mikio Kimura, Ryuichi Kim, Yasumasa Oh
Publikováno v: Vaccine. 10:506-511
An easily administered and safe vaccine is required to produce the herd immunity necessary to control influenza epidemics worldwide. A commercial quadrivalent inactivated split influenza vaccine was administered intranasally in aerosol form to a grou
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::766943b278520b90fceb4867d05b888e
https://doi.org/10.1016/0264-410x(92)90348-n
Zobrazit plný text záznamu
5
Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization
Autor: Harumi Kuno-Sakai, Mikio Kimura
Publikováno v: Pediatrics international : official journal of the Japan Pediatric Society. 46(6)
Background: Real evaluation of any vaccine can only be done after the vaccine has been in routine use for a substantially long period of time. In Japan, acellular pertussis vaccine was introduced and totally replaced whole cell pertussis vaccine in 1
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7240f8148029810e5c43a11d17cdad8a
https://pubmed.ncbi.nlm.nih.gov/15660862
Zobrazit plný text záznamu
6
Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan
Autor: Harumi Kuno-Sakai, Mikio Kimura, Watanabe Hideo
Publikováno v: Biologicals : journal of the International Association of Biological Standardization. 32(1)
An ideal acellular pertussis vaccine is now under investigation worldwide. We have had acellular pertussis vaccines available for the last 22 years, which contributed greatly to the control of pertussis in Japan, although it has not been known whethe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5346942365bf4b28d69d062886f0a943
https://pubmed.ncbi.nlm.nih.gov/15713557
Zobrazit plný text záznamu
9
Developments in pertussis immunisation in Japan
Autor: Harumi Kuno-Sakai, Mikio Kimura
Publikováno v: The Lancet. 336:30-32
In Japan acellular pertussis vaccine has totally replaced whole-cell vaccine since 1981. The vaccine is given in combination with diphtheria and tetanus toxoids to children aged 24-48 months; three doses are given with intervals of 3-8 weeks and the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f660f0e7b01c4194dcbe9a506c5e4f
https://doi.org/10.1016/0140-6736(90)91530-n
Zobrazit plný text záznamu
10
Immunogenicity and reactogenicity of the component acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous haemagglutinin
Autor: Takao Ozaki, Kohji Ueda, Harumi Kuno-Sakai, Michio Koike, Mizuo Hirose, Hitoshi Kamiya, Shin Isomura, Mikio Kimura, Tatsuo Kato, Tsuneyoshi Egami
Publikováno v: Acta paediatrica Japonica : Overseas edition. 37(5)
This is the report on a prospective, single blind, comparative study of a component acellular pertussis vaccine produced by a combination of detoxified, column purified pertussis toxin (PT) and filamentous hemagglutinin (FHA) combined with diphtheria
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d2a0d61445e32a3cb84f1f0ac6f46d8
https://pubmed.ncbi.nlm.nih.gov/8533580
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje